Universal Health Services, Inc.
NYSE:UHSMedical - Care Facilities
-$5.64 today
- Market cap
- $9.38B
- Beta
- 1.08
- P/E (TTM)
- 5.7
- EPS (TTM)
- $24.90
- Dividend yield
- 0.57%
Volume 0.67M
Average 0.94M
UHS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Universal Health Services, Inc.NYSE: UHS
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures declines year over year
Q2 FY2026 capital expenditures of $227.63M (cash outflow) fell 14.4% year over year, behind the -2.5% change in trailing-twelve-month capital expenditures. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at +11.4% a year.
Context
- Capital expenditures amounted to 5.8% of revenue in FY2025, down 0.1 pp from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -14.4% toward the trailing-twelve-month pace of -2.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.02B) USD
- Year-over-year change
- -7.6%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.02B) | -7.6% |
| FY2024 | 2024-12-31 | (943.81M) | -27.0% |
| FY2023 | 2023-12-31 | (743.06M) | -1.2% |
| FY2022 | 2022-12-31 | (734M) | +14.2% |
| FY2021 | 2021-12-31 | (855.66M) | — |
Capital Expenditures vs competitors
How UHS compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -2.5% is the 8th highest of 9, against a peer median of +18.1%.
- Capital expenditures amounts to 5.4% of revenue for UHS, versus a peer median of 3.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.13B USD | +10.4% | +4.0% | 6.6% | |
| LTM Jun 2026 | €1.03B EUR | +46.3% | +6.7% | 5.3% | |
| LTM Jun 2026 | $992M USD | +10.0% | +9.8% | 4.5% | |
| LTM Jun 2026 | $973.58M USD | -2.5% | +11.4% | 5.4% | |
| LTM Mar 2026 | $326M USD | -7.4% | -6.9% | 1.5% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $217.08M USD | +16.4% | +11.9% | 3.4% |
| LTM Jun 2026 | $66.35M USD | +19.8% | +3.1% | 2.6% | |
| LTM Sep 2026 | $21.93M USD | +103.2% | +24.5% | 0.6% | |
| LTM Mar 2026 | $3.66M USD | +124.1% | -44.3% | 0.4% | |
| Peer median (excluding UHS) | — | +18.1% | +5.3% | 3.0% | |
Competitors are the stored peer set for UHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 987.63M | 656.98M | 717.49M | 1.16B | 1.51B |
| Depreciation & Amortization | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M |
| Deferred Income Tax | 26.05M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 73.69M | 85.38M | 87.72M | 99.35M | 95.69M |
| Change in Working Capital | (736.89M) | (244.35M) | 17.07M | 418.76M | (275.89M) |
| Accounts Receivables | (8.87M) | (258.34M) | (182.44M) | 67.36M | (317.99M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (728.02M) | 13.99M | 199.51M | 351.4M | 42.09M |
| Other Non-Cash Items | 0 | (83.85M) | (124.34M) | (198.95M) | (85.32M) |
| Operating Cash Flow | 883.7M | 996.02M | 1.27B | 2.07B | 1.86B |
| Capital Expenditures | (855.66M) | (734M) | (743.06M) | (943.81M) | (1.02B) |
| Acquisitions (Net) | (105.32M) | (20.31M) | (3.73M) | (18.72M) | (31.94M) |
| Purchases of Investments | (1.36M) | 0 | 0 | 0 | (52.21M) |
| Sales of Investments | 0 | 94.91M | 0 | 0 | 0 |
| Other Investing Activities | 46.51M | 12M | (16.51M) | 51.42M | 28.69M |
| Investing Cash Flow | (914.47M) | (647.3M) | (763.28M) | (911.11M) | (1.07B) |
| Debt Repayment | 217.11M | 615.95M | 99.62M | (429.75M) | 241.65M |
| Common Stock Issued | 13.37M | 14.07M | 13.65M | 15.07M | 16.73M |
| Common Stock Repurchased | (1.22B) | (832.92M) | (547.36M) | (670.75M) | (967.95M) |
| Dividends Paid | (65.9M) | (58.45M) | (55.48M) | (53.35M) | (51.27M) |
| Other Financing Activities | 715K | (42.99M) | 9.28M | (6.09M) | 11.11M |
| Financing Cash Flow | (1.07B) | (318.4M) | (493.95M) | (1.14B) | (749.73M) |
| Effect of Forex Changes | (499K) | (8.42M) | 3.06M | (833K) | 2.52M |
| Net Change in Cash | (1.1B) | 21.9M | 13.63M | 10.28M | 46.57M |
| Free Cash Flow | 28.04M | 262.02M | 524.74M | 1.12B | 849.25M |
Universal Health Services, Inc.
NYSE:UHS
Intrinsic Alpha fair value
Locked
Current Price
$186.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.